Global CRO Leader Accutest is a global independent CRO with extensive accreditation Track record across US FDA, WHO, DCGI, and EMA, signaling strong quality and reliability that can reassure potential pharma and biotech clients seeking compliant outsourced development and testing.

Full-Service BIO BE The company offers end-to-end BA/BE studies, clinical development (Phase II-IV and post-marketing), medical writing, regulatory consultancy, and data management, presenting a one-stop outsourcing option for clients aiming to accelerate regulatory submissions and reduce vendor churn.

Biosimilars Focus Biologics services spanning biosimilars, novel biologics, and non-biological complex generics create opportunities to engage biotech firms and mid-cap pharma developing complex products that require specialized testing and regulatory support.

Regulatory Footprint A history of frequent international inspections and approvals (USFDA, WHO, EMA, DCGI) suggests strong compliance culture, which can be leveraged to win tenders from global organizations prioritizing high-quality, audit-ready CRO partners.

Mid-Market Growth With revenue in the mid-range and a staffing scale of several hundred to a thousand, Accutest sits between small boutique CROs and large integrated players, offering scalable collaboration models and competitive pricing for mid-sized pharma/biotech projects seeking efficiency.